Literature DB >> 8620471

Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4 alpha and HNF1 alpha.

S Sel1, T Ebert, G U Ryffel, T Drewes.   

Abstract

Human renal cell carcinogenesis is usually accompanied by dedifferentiation processes including the loss of expression of tissue specifically expressed genes. Based on the hypothesis that these dedifferentiation processes might be attributed to a functional change in tissue specific transcription factors, we have analyzed the expression and function of the tissue specific transcription factor HNF4 alpha in human renal cell carcinomas. By Western blot analysis and gel retardation assay using HNF4 alpha specific antibodies, we observed that in most cases the amount as well as the binding activity of HNF4 is reduced in the tumor samples compared to the corresponding normal tissues. Furthermore, we found a clear correlation between the HNF4 alpha binding activity and the amount of another transcription factor (HNF1 alpha), which is thought to be transcriptionally activated by HNF4 alpha. We therefore speculate that disruption of the HNF4 alpha/HNF1 alpha pathway of kidney specific gene expression might be an important molecular mechanism in renal cell carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620471     DOI: 10.1016/0304-3835(96)04136-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

Review 1.  Network insights into the genes regulated by hepatocyte nuclear factor 4 in response to drug induced perturbations: a review.

Authors:  Asfar S Azmi; Ginny W Bao; Jiankun Gao; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Curr Drug Discov Technol       Date:  2013-06

2.  Inhibitor of the tissue-specific transcription factor HNF4, a potential regulator in early Xenopus development.

Authors:  G Peiler; B Böckmann; H Nakhei; G U Ryffel
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree.

Authors:  J Lausen; H Thomas; I Lemm; M Bulman; M Borgschulze; A Lingott; A T Hattersley; G U Ryffel
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

Review 4.  Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer.

Authors:  Chad Walesky; Udayan Apte
Journal:  Gene Expr       Date:  2015

5.  A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites.

Authors:  Andrea Wirsing; Sabine Senkel; Ludger Klein-Hitpass; Gerhart U Ryffel
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

6.  Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.

Authors:  William W Lockwood; Ian M Wilson; Bradley P Coe; Raj Chari; Larissa A Pikor; Kelsie L Thu; Luisa M Solis; Maria I Nunez; Carmen Behrens; John Yee; John English; Nevin Murray; Ming-Sound Tsao; John D Minna; Adi F Gazdar; Ignacio I Wistuba; Calum E MacAulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

7.  Extensive decoupling of metabolic genes in cancer.

Authors:  Ed Reznik; Chris Sander
Journal:  PLoS Comput Biol       Date:  2015-05-11       Impact factor: 4.475

8.  ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma.

Authors:  Jun Lu; Zhan Chen; Hu Zhao; Huiyue Dong; Ling Zhu; Yi Zhang; Jie Wang; Hehuan Zhu; Qiang Cui; Chuang Qi; Shuiliang Wang; Shushang Chen; Jichun Shao
Journal:  J Transl Med       Date:  2020-02-24       Impact factor: 5.531

9.  Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney.

Authors:  Rohit Mehra; Pankaj Vats; Marcin Cieslik; Xuhong Cao; Fengyun Su; Sudhanshu Shukla; Aaron M Udager; Rui Wang; Jincheng Pan; Katayoon Kasaian; Robert Lonigro; Javed Siddiqui; Kumpati Premkumar; Ganesh Palapattu; Alon Weizer; Khaled S Hafez; J Stuart Wolf; Ankur R Sangoi; Kiril Trpkov; Adeboye O Osunkoya; Ming Zhou; Giovanna Giannico; Jesse K McKenney; Saravana M Dhanasekaran; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2016-09-07       Impact factor: 39.397

10.  Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.

Authors:  Michael J Strong; Guorong Xu; Joseph Coco; Carl Baribault; Dass S Vinay; Michelle R Lacey; Amy L Strong; Teresa A Lehman; Michael B Seddon; Zhen Lin; Monica Concha; Melody Baddoo; Marybeth Ferris; Kenneth F Swan; Deborah E Sullivan; Matthew E Burow; Christopher M Taylor; Erik K Flemington
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.